National Institutes of Health: Malaria trials
The registry lists 124 Malaria studies with National Institutes of Health as lead sponsor. 8 are open to participants now and 19 have results posted.
Phase 1 53Phase 2 12Phase 3 3Phase 4 2No phase 56(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Factors Involved in Resistance to Severe MalariaCompletedNCT00368810
- Relationship Between HIV and Malaria in Ugandan ChildrenCompletedNCT00356824
- Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered IntramuscularlyCompletedNCT00347555Phase 1
- Analysis of the Immune Response to the Malaria Parasite in Mali, West AfricaCompletedNCT00346346
- AMA1-C1/Alhydrogel + CpG 7909 for MalariaCompletedNCT00344539Phase 1
- Experimental Vaccine for Malaria in Adults in MaliCompletedNCT00343005Phase 1
- Examination of Protective Factors Against Severe MalariaCompletedNCT00342043
- Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, MaliTerminatedNCT00341783
- Malaria Vaccine in Children in MaliCompletedNCT00341250Phase 1/2
- Severe Malaria and Anti-malarial Drug Resistance in CambodiaCompletedNCT00341003
- Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)CompletedNCT00340574Phase 1
- Experimental Vaccine for Plasmodium Falciparum MalariaCompletedNCT00340431Phase 1
- Malaria Prevalence in ChildrenCompletedNCT00322816
- Time to Infection With Malaria ParasitesCompletedNCT00322738
- Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 AdjuvantCompletedNCT00320658Phase 1
- Fetal Immunity to Falciparum MalariaCompletedNCT00314899
- SP Resistance and Falciparum Malaria TransmissionWithdrawnNCT00299247Phase 3
- Azithromycin Combination Therapy for MalariaCompletedNCT00299208Phase 2
- PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for MalariaCompletedNCT00295581Phase 1
- Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria ResearchCompletedNCT00277849
- Papua New Guinean Duffy Negativity And Vivax MalarTerminatedNCT00138489
- Correlates of Protection in GhanaCompletedNCT00138307
- CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in MalawiCompletedNCT00125489Phase 4
- Experimental Vaccine for MalariaCompletedNCT00114010Phase 1